We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
-19.46%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
AUM
$166M
AUM Growth
-$120M
Cap. Flow
-$76.3M
Cap. Flow %
-45.92%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CTEV
Claritev Corp
CTEV
+$76.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTEV
1
Claritev Corp
CTEV
$599M
$166M 100%
3,887,858
-1,500,000
-28% -$76.3M

Similar funds

H&F Corporate Investors VIII's Q4 2025 Portfolio in Review

As of Q4 2025, H&F Corporate Investors VIII held 1 position worth $166M, down 42% from $286M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

H&F Corporate Investors VIII withdrew a net $76.3M in Q4 2025, reducing 1 holding. Its largest reduction was Claritev Corp, cutting an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • H&F Corporate Investors VIII's biggest Q4 2025 reduction was Claritev Corp, cutting an estimated $76.3M.
  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $166M portfolio in Q4 2025.
  • H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q4 2025.
  • H&F Corporate Investors VIII's portfolio value fell 42% quarter-over-quarter to $166M.

Based on H&F Corporate Investors VIII's 13F filing for Q4 2025, filed 13 Feb 2026.